Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients.
- Resource Type
- journal article
- Source
- BMC Nephrology; 9/6/2022, Vol. 23 Issue 1, p1-9, 9p
- Subject
RECEPTOR antibodies KIDNEY diseases CHRONIC kidney failure TREATMENT effectiveness ANTIBODY titer SERUM albumin - Language
- ISSN
- 14712369